These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 16618941)
21. Androgens and the breast. von Schoultz B Maturitas; 2007 May; 57(1):47-9. PubMed ID: 17386984 [TBL] [Abstract][Full Text] [Related]
22. Expression of prostate-specific antigen and androgen receptor in extramammary Paget's disease and carcinoma. Inoguchi N; Matsumura Y; Kanazawa N; Morita K; Tachibana T; Sakurai T; Utani A; Miyachi Y Clin Exp Dermatol; 2007 Jan; 32(1):91-4. PubMed ID: 17163959 [TBL] [Abstract][Full Text] [Related]
23. Increased arterial stiffness in female-to-male transsexuals treated with androgen. Emi Y; Adachi M; Sasaki A; Nakamura Y; Nakatsuka M J Obstet Gynaecol Res; 2008 Oct; 34(5):890-7. PubMed ID: 18834347 [TBL] [Abstract][Full Text] [Related]
24. Testosterone stimulates growth and secretory activity of the female prostate in the adult gerbil (Meriones unguiculatus). Santos FC; Leite RP; Custódio AM; Carvalho KP; Monteiro-Leal LH; Santos AB; Góes RM; Carvalho HF; Taboga SR Biol Reprod; 2006 Sep; 75(3):370-9. PubMed ID: 16707769 [TBL] [Abstract][Full Text] [Related]
25. Human kallikrein 10, a predictive marker for breast cancer. Zhang Y; Bhat I; Zeng M; Jayal G; Wazer DE; Band H; Band V Biol Chem; 2006 Jun; 387(6):715-21. PubMed ID: 16800732 [TBL] [Abstract][Full Text] [Related]
26. Review of studies of androgen treatment of female-to-male transsexuals: effects and risks of administration of androgens to females. Gooren LJG; Giltay EJ J Sex Med; 2008 Apr; 5(4):765-776. PubMed ID: 17971101 [TBL] [Abstract][Full Text] [Related]
27. Serum and urinary prostate-specific antigen and urinary human glandular kallikrein concentrations are significantly increased after testosterone administration in female-to-male transsexuals. Obiezu CV; Giltay EJ; Magklara A; Scorilas A; Gooren LJ; Yu H; Howarth DJ; Diamandis EP Clin Chem; 2000 Jun; 46(6 Pt 1):859-62. PubMed ID: 10839777 [TBL] [Abstract][Full Text] [Related]
28. Higher expression of the androgen-regulated gene PSA/HK3 mRNA in prostate cancer tissues predicts biochemical recurrence-free survival. Sterbis JR; Gao C; Furusato B; Chen Y; Shaheduzzaman S; Ravindranath L; Osborn DJ; Rosner IL; Dobi A; McLeod DG; Sesterhenn IA; Srivastava S; Cullen J; Petrovics G Clin Cancer Res; 2008 Feb; 14(3):758-63. PubMed ID: 18245536 [TBL] [Abstract][Full Text] [Related]
29. Effects on the male endocrine system of long-term treatment with gonadotropin-releasing hormone agonists and estrogens in male-to-female transsexuals. Mueller A; Binder H; Cupisti S; Hoffmann I; Beckmann MW; Dittrich R Horm Metab Res; 2006 Mar; 38(3):183-7. PubMed ID: 16673210 [TBL] [Abstract][Full Text] [Related]
31. Breast cancer in female-to-male transsexuals: two cases with a review of physiology and management. Shao T; Grossbard ML; Klein P Clin Breast Cancer; 2011 Dec; 11(6):417-9. PubMed ID: 21831723 [TBL] [Abstract][Full Text] [Related]
32. Regulation of global gene expression in the bone marrow microenvironment by androgen: androgen ablation increases insulin-like growth factor binding protein-5 expression. Xu C; Graf LF; Fazli L; Coleman IM; Mauldin DE; Li D; Nelson PS; Gleave M; Plymate SR; Cox ME; Torok-Storb BJ; Knudsen BS Prostate; 2007 Nov; 67(15):1621-9. PubMed ID: 17823924 [TBL] [Abstract][Full Text] [Related]
33. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate. Sheridan T; Herawi M; Epstein JI; Illei PB Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190 [TBL] [Abstract][Full Text] [Related]
34. Cellular distribution of human tissue kallikreins: immunohistochemical localization. Petraki CD; Papanastasiou PA; Karavana VN; Diamandis EP Biol Chem; 2006 Jun; 387(6):653-63. PubMed ID: 16800726 [TBL] [Abstract][Full Text] [Related]
35. Effects of sex steroids on the neurotransmitter-specific aromatic amino acids phenylalanine, tyrosine, and tryptophan in transsexual subjects. Giltay EJ; Bunck MC; Gooren LJ; Zitman FG; Diamant M; Teerlink T Neuroendocrinology; 2008; 88(2):103-10. PubMed ID: 18511863 [TBL] [Abstract][Full Text] [Related]
36. Cellular changes in prostate cancer cells induced by intermittent androgen suppression. Laitinen S; Martikainen PM; Tammela TL; Visakorpi T Eur Urol; 2007 Sep; 52(3):725-32. PubMed ID: 17141945 [TBL] [Abstract][Full Text] [Related]
37. Safety of physiological testosterone therapy in women: lessons from female-to-male transsexuals (FMT) treated with pharmacological testosterone therapy. Traish AM; Gooren LJ J Sex Med; 2010 Nov; 7(11):3758-64. PubMed ID: 20722789 [TBL] [Abstract][Full Text] [Related]
38. Characterization of human kallikreins 6 and 10 in ascites fluid from ovarian cancer patients. Luo LY; Soosaipillai A; Grass L; Diamandis EP Tumour Biol; 2006; 27(5):227-34. PubMed ID: 16864975 [TBL] [Abstract][Full Text] [Related]
39. Serum and urine tissue kallikrein concentrations in male-to-female transsexuals treated with antiandrogens and estrogens. Slagter MH; Gooren LJ; de Ronde W; Soosaipillai A; Scorilas A; Giltay EJ; Paliouras M; Diamandis EP Clin Chem; 2006 Jul; 52(7):1356-65. PubMed ID: 16644872 [TBL] [Abstract][Full Text] [Related]
40. Androgen sensitivity of prostate epithelium is enhanced by postnatal androgen receptor inactivation. Simanainen U; McNamara K; Gao YR; Handelsman DJ Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1335-43. PubMed ID: 19366880 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]